Compounds > 1,3-dipropyl-8-(4-sulfophenyl)xanthine
Page last updated: 2024-10-21

1,3-dipropyl-8-(4-sulfophenyl)xanthine and Goldblatt Syndrome

1,3-dipropyl-8-(4-sulfophenyl)xanthine has been researched along with Goldblatt Syndrome in 1 studies

1,3-dipropyl-8-(4-sulfophenyl)xanthine: adenosine receptor antagonist

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuan, CJ1
Wells, JN1
Jackson, EK1

Other Studies

1 other study available for 1,3-dipropyl-8-(4-sulfophenyl)xanthine and Goldblatt Syndrome

ArticleYear
Endogenous adenosine restrains renin release in conscious rats.
    Circulation research, 1990, Volume: 66, Issue:3

    Topics: Adenine; Adenosine; Adenosine Deaminase; Animals; Hydralazine; Hypertension, Renovascular; Male; Rat

1990